Compare Heartflow Inc. Common Stock (HTFL) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heartflow Inc. Common Stock vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Heartflow Inc. Common Stock trades at $49.44 (market cap $4.38B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Heartflow Inc. Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| HTFL | IONS | |
|---|---|---|
Market Cap | $4.38B | $7.04B |
Volume | 1,454,420 | 2,977,440 |
Sector | Health | Health |
52-Week High | $52.21 | $86.50 |
52-Week Low | $20.49 | $42.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.24B | $6.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heartflow Inc. Common Stock
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
